Chip Zug

Chip Zug currently serves as the Global Analytics & Insights Lead for the Global Alzheimer's Disease Office at Eisai US, where responsibilities include leading a team focused on forecasting and analytics to support a significant Alzheimer's treatment strategy. Prior experience includes a role as Global Insights & Analytics Leader at ViiV Healthcare, managing a diverse team to optimize business strategies, and holding leadership positions such as New Products Leader and Market & Portfolio Strategy Leader at GlaxoSmithKline, directing impactful market analysis in the field of infectious diseases. Early career roles include financial analysis at JP Morgan and Hambrecht & Quist, where management of substantial client portfolios was a key responsibility. Educational credentials include an MBA from the University of Virginia Darden School of Business and a BA in History & PreMed from the University of Virginia.